把三张表、经营指标、SEC / 巨潮 / 港交所原始财报、业绩材料和电话会放到同一条可核验时间线上。 披露事实、结构化补位值与派生指标分开标注,缺失逐字稿不会用摘要或模型生成内容补齐。
单季、累计、年度和资产负债表时点分开保存;每个数值都保留单位、申报日、表单、XBRL 概念或原始中文字段。
美股链接 SEC 法定申报和发行人 IR,A 股链接巨潮原始 PDF,港股链接港交所披露易原始年报与中报。分部、订单、产能和客户集中度只在有可核验披露时展示。
官方电话会入口与已授权逐字稿分开。没有合法取得的全文时只显示材料可用性,不生成或拼接虚假的逐字稿。
三张表会执行资产负债、毛利润、税前利润等勾稽检查;超出容差的记录保留原值并标记警告, 不会为了让公式“对上”而修改公司披露。
| 2026-06-30 |
| 3/3 |
| $3.99B |
| $298M |
| $2B |
| 70.7% |
| 4.1% |
| 49 |
| 尚无授权文本 |
| NVNO enVVeno Medical Corp | 2026-06-30 | 3/3 | — | -$3.6M | — | — | — | 57 | 尚无授权文本 |
| ENVX Enovix Corp | 2026-04-05 | 3/3 | $7.6M | -$38.26M | -$36.29M | 20.4% | -577.6% | 98 | 尚无授权文本 |
| ENOV Enovis CORP | 2026-04-03 | 3/3 | $589.15M | -$8.76M | -$28.85M | 62.0% | 1.1% | 94 | 尚无授权文本 |
| BNGO Bionano Genomics, Inc. | 2026-03-31 | 3/3 | $6.69M | -$8.3M | — | 48.6% | -118.1% | 112 | 尚无授权文本 |
| GCMG GCM Grosvenor Inc. | 2026-03-31 | 3/3 | $124.78M | $5.47M | $47.88M | — | 16.4% | 67 | 尚无授权文本 |
| MGX Metagenomi Therapeutics, Inc. | 2026-03-31 | 3/3 | $1.25M | -$23.06M | -$21.2M | — | -1970.1% | 31 | 尚无授权文本 |
| NEO NEOGENOMICS INC | 2026-03-31 | 3/3 | — | -$17.11M | -$13.14M | — | — | 107 | 尚无授权文本 |
| OLOX OLENOX INDUSTRIES INC. | 2026-03-31 | 3/3 | $285,313 | -$2.67M | — | -70.4% | -1010.5% | 205 | 尚无授权文本 |
| RDNW RideNow Group, Inc. | 2026-03-31 | 3/3 | $260.4M | -$4.3M | -$28.2M | 27.5% | 2.9% | 140 | 尚无授权文本 |
| RNXT RenovoRx, Inc. | 2026-03-31 | 3/3 | $563,000 | -$3.52M | -$3.71M | 85.1% | -616.2% | 71 | 尚无授权文本 |
| TNON Tenon Medical, Inc. | 2026-03-31 | 3/3 | $1.38M | -$3.48M | -$3.02M | 68.5% | -237.9% | 65 | 尚无授权文本 |
| TRNO Terreno Realty Corp | 2026-03-31 | 3/3 | $124.44M | $69.43M | — | — | — | 55 | 尚无授权文本 |
| TXG 10x Genomics, Inc. | 2026-03-31 | 3/3 | $150.84M | -$13.47M | $24.52M | 70.4% | -11.3% | 71 | 尚无授权文本 |
| XENE Xenon Pharmaceuticals Inc. | 2026-03-31 | 3/3 | — | -$102.3M | -$89.03M | — | — | 90 | 尚无授权文本 |
| CVE CENOVUS ENERGY INC. | 2025-12-31 | 2/3 | — | $3.93B | — | — | — | 163 | 尚无授权文本 |
| KEN Kenon Holdings Ltd. | 2025-12-31 | 2/3 | — | $148.26M | — | — | — | 201 | 尚无授权文本 |
| EDN EDENOR | 2024-12-31 | 2/3 | — | $272.13B | — | — | — | 268 | 尚无授权文本 |
| ENO ENTERGY NEW ORLEANS, LLC | — | 0/3 | — | — | — | — | — | 92 | 尚无授权文本 |